Pages that link to "Q34659332"
Jump to navigation
Jump to search
The following pages link to Kras as a key oncogene and therapeutic target in pancreatic cancer (Q34659332):
Displaying 50 items.
- Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer (Q26764921) (← links)
- Noncoding RNAs and pancreatic cancer (Q26774630) (← links)
- Novel agents for advanced pancreatic cancer (Q26787087) (← links)
- Pancreatic cancer, treatment options, and GI-4000 (Q28083814) (← links)
- Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy (Q28547017) (← links)
- Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling (Q28552433) (← links)
- Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification (Q28822225) (← links)
- Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier (Q31060752) (← links)
- Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward (Q33624574) (← links)
- Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. (Q33838679) (← links)
- Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation (Q34104152) (← links)
- Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells (Q34405468) (← links)
- Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer (Q34537580) (← links)
- The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome (Q34690409) (← links)
- Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies (Q35136815) (← links)
- KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines. (Q35597456) (← links)
- Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer (Q35612378) (← links)
- Pancreatic cancer, treatment options, and GI-4000. (Q35887099) (← links)
- A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD (Q35981873) (← links)
- Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells. (Q36016816) (← links)
- Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase. (Q36121107) (← links)
- Mutant K-RAS Promotes Invasion and Metastasis in Pancreatic Cancer Through GTPase Signaling Pathways (Q36180749) (← links)
- Molecular Imaging with MRI: Potential Application in Pancreatic Cancer (Q36249508) (← links)
- The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma (Q36540519) (← links)
- Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3 (Q36546544) (← links)
- Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras. (Q36562030) (← links)
- Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis (Q36629420) (← links)
- Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy (Q36782324) (← links)
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma (Q37123636) (← links)
- Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus (Q37238133) (← links)
- The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer (Q37271741) (← links)
- Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer (Q37569554) (← links)
- miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer (Q37582210) (← links)
- Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells (Q37702589) (← links)
- Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway (Q37725431) (← links)
- Interleukin-6: a villain in the drama of pancreatic cancer development and progression (Q38237583) (← links)
- Genetic modification of hypoxia signaling in animal models and its effect on cancer (Q38263349) (← links)
- MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis. (Q38471156) (← links)
- The need for effective pancreatic cancer detection and management: a biomarker-based strategy (Q38591066) (← links)
- Direct Modulation of Small GTPase Activity and Function (Q38608107) (← links)
- Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges (Q38680160) (← links)
- Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma (Q38714341) (← links)
- MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment (Q38818609) (← links)
- The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma (Q40998982) (← links)
- HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. (Q41369888) (← links)
- Analysis of K-Ras Interactions by Biotin Ligase Tagging. (Q41525845) (← links)
- Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas (Q46092740) (← links)
- T-cell Acute Lymphoblastic Leukemia Cells Display Activation of Different Survival Pathways. (Q47104126) (← links)
- MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating (Q58588518) (← links)
- Capture and biological release of circulating tumor cells in pancreatic cancer based on peptide-functionalized silicon nanowire substrate (Q60934953) (← links)